{"id":"https://openalex.org/W3133558396","doi":"https://doi.org/10.3390/pharmaceutics13030363","title":"ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries","display_name":"ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries","publication_year":2021,"publication_date":"2021-03-10","ids":{"openalex":"https://openalex.org/W3133558396","doi":"https://doi.org/10.3390/pharmaceutics13030363","mag":"3133558396","pmid":"https://pubmed.ncbi.nlm.nih.gov/33801796","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8001157"},"language":"en","primary_location":{"id":"doi:10.3390/pharmaceutics13030363","doi":"https://doi.org/10.3390/pharmaceutics13030363","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics13030363","pdf_url":"https://www.mdpi.com/1999-4923/13/3/363/pdf?version=1615357348","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1999-4923/13/3/363/pdf?version=1615357348","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Claudia Miranda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018837529","display_name":"Universidad Central \"Marta Abreu\" de las Villas (UCLV)","ror":"https://ror.org/01cdy6h50","country_code":"CU","type":"education","lineage":["https://openalex.org/I3018837529"]}],"countries":["CU"],"is_corresponding":false,"raw_author_name":"Claudia Miranda","raw_affiliation_strings":["Centro de Bioactivos Qu\u00edmicos, Unit of Modeling & Experimental Biopharmaceutics, Universidad Central \u201cMarta Abreu\u201d de Las Villas, 54830 Santa Clara, Cuba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Bioactivos Qu\u00edmicos, Unit of Modeling & Experimental Biopharmaceutics, Universidad Central \u201cMarta Abreu\u201d de Las Villas, 54830 Santa Clara, Cuba","institution_ids":["https://openalex.org/I3018837529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067391039","display_name":"Alexis Aceituno","orcid":"https://orcid.org/0000-0002-0960-8413","observed_orcids":["https://orcid.org/0000-0002-0960-8413"]},"institutions":[{"id":"https://openalex.org/I4210089334","display_name":"Instituto de Salud P\u00fablica de Chile","ror":"https://ror.org/0080ttk76","country_code":"CL","type":"healthcare","lineage":["https://openalex.org/I4210089334","https://openalex.org/I4210109244","https://openalex.org/I4210122724"]},{"id":"https://openalex.org/I79274474","display_name":"University of Valpara\u00edso","ror":"https://ror.org/00h9jrb69","country_code":"CL","type":"education","lineage":["https://openalex.org/I79274474"]}],"countries":["CL"],"is_corresponding":false,"raw_author_name":"Alexis Aceituno","raw_affiliation_strings":["Faculty of Pharmacy, University of Valparaiso, 2340000 Valparaiso, Chile","National Drug Agency Department, Institute of Public Health, 7780050 Santiago, Chile"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, University of Valparaiso, 2340000 Valparaiso, Chile","institution_ids":["https://openalex.org/I79274474"]},{"raw_affiliation_string":"National Drug Agency Department, Institute of Public Health, 7780050 Santiago, Chile","institution_ids":["https://openalex.org/I4210089334"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001957791","display_name":"Mirna Fern\u00e1ndez Cervera","orcid":"https://orcid.org/0000-0001-6537-3367","observed_orcids":["https://orcid.org/0000-0001-6537-3367"]},"institutions":[{"id":"https://openalex.org/I2656126","display_name":"University of Havana","ror":"https://ror.org/04204gr61","country_code":"CU","type":"education","lineage":["https://openalex.org/I2656126"]}],"countries":["CU"],"is_corresponding":false,"raw_author_name":"Mirna Fern\u00e1ndez","raw_affiliation_strings":["Department of Pharmacy, Institute of Pharmacy and Foods, 17100 Havana, Cuba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Institute of Pharmacy and Foods, 17100 Havana, Cuba","institution_ids":["https://openalex.org/I2656126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014061844","display_name":"Gustavo Duarte Mendes","orcid":"https://orcid.org/0000-0001-8700-5709","observed_orcids":["https://orcid.org/0000-0001-8700-5709"]},"institutions":[{"id":"https://openalex.org/I4405271689","display_name":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria","ror":"https://ror.org/02vhxmj78","country_code":"BR","type":"government","lineage":["https://openalex.org/I4405271689"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Gustavo Mendes","raw_affiliation_strings":["General Office of Medicines and Biological Products, Brazilian Health Regulatory Agency, 71205-050 Brasilia, DF, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Office of Medicines and Biological Products, Brazilian Health Regulatory Agency, 71205-050 Brasilia, DF, Brazil","institution_ids":["https://openalex.org/I4405271689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018350406","display_name":"Yanina I. Rodr\u00edguez","orcid":"https://orcid.org/0000-0001-8228-9650","observed_orcids":["https://orcid.org/0000-0001-8228-9650"]},"institutions":[{"id":"https://openalex.org/I4389425446","display_name":"Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica","ror":"https://ror.org/05kxnq107","country_code":"AR","type":"government","lineage":["https://openalex.org/I4389425446"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Yanina Rodr\u00edguez","raw_affiliation_strings":["Laboratorio Nacional de Control, Direcci\u00f3n de Fiscalizaci\u00f3n y Gesti\u00f3n de Riesgo, Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica, C1084AAD Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio Nacional de Control, Direcci\u00f3n de Fiscalizaci\u00f3n y Gesti\u00f3n de Riesgo, Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica, C1084AAD Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4389425446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016501663","display_name":"Ver\u00f3nica Llaur\u00f3","orcid":"https://orcid.org/0009-0001-3875-0136","observed_orcids":["https://orcid.org/0009-0001-3875-0136"]},"institutions":[{"id":"https://openalex.org/I4389425446","display_name":"Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica","ror":"https://ror.org/05kxnq107","country_code":"AR","type":"government","lineage":["https://openalex.org/I4389425446"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Ver\u00f3nica Llaur\u00f3","raw_affiliation_strings":["Laboratorio Nacional de Control, Direcci\u00f3n de Fiscalizaci\u00f3n y Gesti\u00f3n de Riesgo, Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica, C1084AAD Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio Nacional de Control, Direcci\u00f3n de Fiscalizaci\u00f3n y Gesti\u00f3n de Riesgo, Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica, C1084AAD Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4389425446"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042970171","display_name":"Miguel \u00c1ngel Cabrera\u2010P\u00e9rez","orcid":"https://orcid.org/0000-0001-5897-2230","observed_orcids":["https://orcid.org/0000-0001-5897-2230"]},"institutions":[{"id":"https://openalex.org/I3018837529","display_name":"Universidad Central \"Marta Abreu\" de las Villas (UCLV)","ror":"https://ror.org/01cdy6h50","country_code":"CU","type":"education","lineage":["https://openalex.org/I3018837529"]}],"countries":["CU"],"is_corresponding":true,"raw_author_name":"Miguel \u00c1ngel Cabrera-P\u00e9rez","raw_affiliation_strings":["Centro de Bioactivos Qu\u00edmicos, Unit of Modeling & Experimental Biopharmaceutics, Universidad Central \u201cMarta Abreu\u201d de Las Villas, 54830 Santa Clara, Cuba"],"raw_orcid":"https://orcid.org/0000-0001-5897-2230","affiliations":[{"raw_affiliation_string":"Centro de Bioactivos Qu\u00edmicos, Unit of Modeling & Experimental Biopharmaceutics, Universidad Central \u201cMarta Abreu\u201d de Las Villas, 54830 Santa Clara, Cuba","institution_ids":["https://openalex.org/I3018837529"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5042970171"],"corresponding_institution_ids":["https://openalex.org/I3018837529"],"apc_list":{"value":2200,"currency":"CHF","value_usd":2376},"apc_paid":{"value":2200,"currency":"CHF","value_usd":2376},"fwci":0.8112,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.62153958,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"13","issue":"3","first_page":"363","last_page":"363"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.8398000001907349,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.8398000001907349,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.059300001710653305,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.03180000185966492,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biopharmaceutics-classification-system","display_name":"Biopharmaceutics Classification System","score":0.9300000071525574},{"id":"https://openalex.org/keywords/biowaiver","display_name":"biowaiver","score":0.8529999852180481},{"id":"https://openalex.org/keywords/regulatory-harmonization","display_name":"regulatory harmonization","score":0.8999999761581421},{"id":"https://openalex.org/keywords/latin-america","display_name":"Latin America","score":0.7839999794960022},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.7409999966621399},{"id":"https://openalex.org/keywords/in-vitro-dissolution-testing","display_name":"in vitro dissolution testing","score":0.800000011920929},{"id":"https://openalex.org/keywords/solubility","display_name":"solubility","score":0.7369999885559082},{"id":"https://openalex.org/keywords/permeability","display_name":"permeability","score":0.8399999737739563},{"id":"https://openalex.org/keywords/generic-drug-development","display_name":"generic drug development","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.7864771485328674},{"id":"https://openalex.org/C2779962950","wikidata":"https://www.wikidata.org/wiki/Q5659376","display_name":"Harmonization","level":2,"score":0.7198833227157593},{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.6523010730743408},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.5904224514961243},{"id":"https://openalex.org/C2910701995","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutics","level":5,"score":0.5518372058868408},{"id":"https://openalex.org/C158886217","wikidata":"https://www.wikidata.org/wiki/Q16799549","display_name":"Latin Americans","level":2,"score":0.5448437333106995},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.5331816673278809},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.49893903732299805},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.44100427627563477},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.43134698271751404},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.42513948678970337},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40019091963768005},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3235318660736084},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32207250595092773},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.283638596534729},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.22787481546401978},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.17830145359039307},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.12145525217056274},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.10217565298080444},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0},{"id":"https://openalex.org/C160492267","wikidata":"https://www.wikidata.org/wiki/Q319616","display_name":"Pharmacognosy","level":4,"score":0.0},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3390/pharmaceutics13030363","doi":"https://doi.org/10.3390/pharmaceutics13030363","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics13030363","pdf_url":"https://www.mdpi.com/1999-4923/13/3/363/pdf?version=1615357348","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:33801796","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33801796","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8001157","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8001157/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:7203f82c09e24e61afaee444a8c82dd6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7203f82c09e24e61afaee444a8c82dd6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics, Vol 13, Iss 3, p 363 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/pharmaceutics13030363","doi":"https://doi.org/10.3390/pharmaceutics13030363","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics13030363","pdf_url":"https://www.mdpi.com/1999-4923/13/3/363/pdf?version=1615357348","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.504800021648407,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3133558396.pdf","grobid_xml":"https://content.openalex.org/works/W3133558396.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W228729118","https://openalex.org/W1498305210","https://openalex.org/W1970728958","https://openalex.org/W2090138592","https://openalex.org/W2093752331","https://openalex.org/W2133849435","https://openalex.org/W2291667458","https://openalex.org/W2594847000","https://openalex.org/W2785965975","https://openalex.org/W2883054332","https://openalex.org/W2943749004","https://openalex.org/W2946720417","https://openalex.org/W2995012576","https://openalex.org/W3038099283","https://openalex.org/W6771718699"],"related_works":["https://openalex.org/W3038099283","https://openalex.org/W2522597785","https://openalex.org/W3046663741","https://openalex.org/W4396622059","https://openalex.org/W2785965975","https://openalex.org/W2343390009","https://openalex.org/W2493133468","https://openalex.org/W2604564924","https://openalex.org/W2995012576","https://openalex.org/W2884064719"],"abstract_inverted_index":{"The":[0],"biopharmaceutical":[1],"classification":[2,41],"system":[3,42],"(BCS)":[4],"is":[5,143],"a":[6,108,170],"very":[7],"important":[8],"tool":[9],"to":[10,67,146,163,167,175],"replace":[11],"the":[12,30,39,44,53,59,62,65,78,92,128,147,157,182],"traditional":[13],"in":[14,19,48,64,136,156,187],"vivo":[15],"bioequivalence":[16],"studies":[17,179],"with":[18,127],"vitro":[20],"dissolution":[21,118],"assays":[22],"during":[23],"multisource":[24,72,154],"product":[25],"development.":[26],"This":[27,141],"paper":[28],"compares":[29],"most":[31],"recent":[32],"harmonized":[33],"guideline":[34,96],"for":[35],"biowaivers":[36],"based":[37],"on":[38],"biopharmaceutics":[40],"and":[43,51,58,70,75,80,91,99,105,117,139,152,189],"BCS":[45,55,83,111,177],"regulatory":[46,56,89,122],"guidelines":[47,84],"Latin":[49,87,158],"America":[50],"analyzes":[52],"current":[54],"requirements":[57],"perspective":[60],"of":[61,85,150,185],"harmonization":[63,95],"region":[66],"develop":[68,176],"safe":[69,151],"effective":[71,153],"products.":[73],"Differences":[74],"similarities":[76,126],"between":[77],"official":[79],"publicly":[81],"available":[82],"several":[86],"American":[88,159],"authorities":[90],"new":[93],"ICH":[94,129],"were":[97],"identified":[98],"compared.":[100],"Only":[101],"Chile,":[102],"Brazil,":[103],"Colombia,":[104],"Argentina":[106],"have":[107,124],"more":[109],"comprehensive":[110],"guideline,":[112],"which":[113],"includes":[114],"solubility,":[115],"permeability,":[116],"requirements.":[119],"Although":[120],"their":[121,137,165],"documents":[123],"many":[125],"guidelines,":[130],"there":[131],"are":[132],"still":[133],"major":[134],"differences":[135],"interpretation":[138],"application.":[140],"situation":[142],"an":[144],"obstacle":[145],"successful":[148],"development":[149],"products":[155],"region,":[160],"not":[161],"only":[162],"improve":[164],"access":[166],"patients":[168],"at":[169],"reasonable":[171],"cost,":[172],"but":[173],"also":[174],"biowaiver":[178],"that":[180],"fulfill":[181],"quality":[183],"standards":[184],"regulators":[186],"developed":[188],"emerging":[190],"markets.":[191]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-03-15T00:00:00"}